Yi Zhang

Title: Yi Zhang - Innovator in Influenza Virus Adaptation and Cancer Treatment

Introduction

Yi Zhang is a prominent inventor based in Singapore, known for his significant contributions to the fields of virology and oncology. With a total of five patents to his name, he has developed innovative methods and compositions that have the potential to impact public health and cancer treatment.

Latest Patents

One of Yi Zhang's latest patents is a method for adapting influenza viruses to Vero cells. This method involves infecting Vero cells with the influenza virus, cultivating the infected cells, and harvesting the influenza viruses from each passage. The infectious dose of the influenza viruses from one passage is greater than or equal to that of the previous passage. Additionally, he has developed a composition comprising polyriboinosinic acid-polyribocytidylic acid, antibiotics or polyamide compounds, positive ions, and influenza viruses or antigens derived from Vero cell-adapted influenza viruses. Another notable patent is a composition for the treatment of cancer, which includes polyinosinic-polycytidylic acid, antibiotics or polyamine compounds, positive ions, and optionally a virus, intended for use in manufacturing a medicament for cancer treatment.

Career Highlights

Yi Zhang has worked with notable organizations such as Yisheng Biopharma Pte Ltd and Nanyang Technological University. His work in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Throughout his career, Yi Zhang has collaborated with esteemed colleagues, including Yuhe Yan and Thomas Anthony Coton. These partnerships have fostered innovation and the sharing of knowledge in their respective fields.

Conclusion

Yi Zhang's work exemplifies the intersection of innovation and healthcare, particularly in the adaptation of influenza viruses and the development of cancer treatments. His contributions continue to pave the way for advancements in medical science.